233272-34-9Relevant academic research and scientific papers
Enantioselective synthesis of constrained phenylalanine analogues
Chaturvedula, Prasad V.,Mercer, Stephen E.,Guernon, Leatte,MacOr, John E.,Dubowchik, Gene M.
scheme or table, p. 5588 - 5591 (2010/10/19)
Constrained phenylalanine derivatives containing hydrophobic groups and hydrogen bond acceptor and/or donor functionalities were synthesized through a tandem palladium-mediated Heck reaction followed by a rhodium(II)-catalyzed asymmetric hydrogenation. Ar
Novel tetrahydroisoquinoline derivatives with inhibitory activities against acyl-CoA: Cholesterol acyltransferase and lipid peroxidation
Ohta, Masaru,Takahashi, Kenji,Kasai, Masayasu,Shoji, Yoshimichi,Kunishiro, Kazuyoshi,Miike, Tomohiro,Kanda, Mamoru,Mukai, Chisato,Shirahase, Hiroaki
experimental part, p. 1066 - 1076 (2010/11/16)
To find a novel acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor with anti-lipid peroxidative activity, a series of tetrahydroisoquinoline derivatives were synthesized and evaluated. A compound with a N-(4-hydroxy-2,3,5-trimethylphenyl)carbamoyl moi
TETRAHYDROISOQUINOLINE COMPOUND AND MEDICINAL USE THEREOF
-
Page/Page column 45, (2010/11/28)
The present invention provide a tetrahydroisoquinoline compound having a superior ACAT-inhibitory activity and/or anti-oxidation action, particularly, novel compound represented by the formula (I) (wherein each symbol is as described in the specification) and a pharmaceutically acceptable salt thereof.
3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N- methyltransferase versus the α2-adrenoceptor(1a)
Grunewald, Gary L.,Dahanukar, Vilas H.,Teoh, Bee,Criscione, Kevin R.
, p. 1982 - 1990 (2007/10/03)
3-Hydroxymethyl-1,2,3,4-tetrahydroisoquinoline (4) is a more selective inhibitor (PNMT K(i) = 1.1 μM, α2 K(i) = 6.6 μM, selectivity (α2 K(i)/PNMT K(i)) = 6.0) of phenylethanolamine N-methyltransferase (PNMT, EC 2.1.1.28), with respec
